Laszlo Rejto
Nyiregyhaza, SZ 4400, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Ixazomib-Lenalidomide-Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: A Hungarian Real-World Analysis.
Journal: Journal of clinical medicine
Published: December 01, 2025
Enhancing detection of central nervous system involvement in multiple myeloma: A novel multidimensional dot-plot based analysis for flow cytometry.
Journal: Cytometry. Part B, Clinical cytometry
Published: December 23, 2024
The roles of phosphorylation of signaling proteins in the prognosis of acute myeloid leukemia.
Journal: Pathology oncology research : POR
Published: February 26, 2024
Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.
Journal: The journal of pathology. Clinical research
Published: July 26, 2023
Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma.
Journal: Thrombosis research
Published: July 24, 2023
Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated protein C.
Journal: Thrombosis research
Published: November 30, 2022
Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers.
Journal: Pathology oncology research : POR
Published: December 19, 2021
Circulating microRNA sequencing revealed miRNome patterns in hematology and oncology patients aiding the prognosis of invasive aspergillosis.
Journal: Scientific reports
Published: September 09, 2021
Screening and monitoring of the BTKC481S mutation in a real-world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy.
Journal: British journal of haematology
Published: January 25, 2021
Free circulating mircoRNAs support the diagnosis of invasive aspergillosis in patients with hematologic malignancies and neutropenia.
Journal: Scientific reports
Published: December 09, 2019
Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia.
Journal: American journal of hematology
Published: October 22, 2019
Quantitative Analysis of Carbonic Anhydrase IX Uncovers Hypoxia-Related Functional Differences in Classical Hodgkin Lymphoma Subtypes.
Journal: International journal of molecular sciences
Published: May 31, 2019
Last Updated: 09/26/2026